Headache News and Research

Latest Headache News and Research

Mass-media advertising encourages people with stroke symptoms to go to hospital more quickly

Mass-media advertising can encourage more people experiencing stroke symptoms to go to the hospital more quickly, according to a study published in Stroke: Journal of the American Heart Association.

1 Jun 2007

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007

FDA approves treatment for bacterial vaginosis

Mission Pharmacal has announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States.

28 May 2007

Reversal of coma with an injection of glue

Neurosurgeons and neuroradiologists at Cedars-Sinai Medical Center injected a biosynthetic “glue” to seal off a spinal fluid leak and restore a comatose patient to consciousness.

28 May 2007

Daytrana provides significant effectiveness in both boys and girls with ADHD

Shire plc has announced that DAYTRANA (methylphenidate transdermal system), its Attention Deficit Hyperactivity Disorder (ADHD) patch, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association (APA) annual meeting in San Diego.

24 May 2007

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

A new study demonstrated that the active ingredient in AMITIZA (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C).

22 May 2007

Large trial to identify the long-term health effects of West Nile virus infection

UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease's progression, symptoms and mortality.

18 May 2007

Cedars-Sinai helps Doug Fieger battle brain tumors

When singer/songwriter/guitarist Doug Fieger, lead singer of The Knack, found out last year that he had two brain tumors, he was concerned that either the tumors or the side effects of surgery would leave him unable to pursue his livelihood.

16 May 2007

Middle-aged men and women with a history of migraine and other headaches are more likely to have retinopathy

Twenty-two percent of the participants had a history of migraine or other headaches. Those with a history of headaches were slightly younger, more likely to be female, and more likely to be white than those without a history of headaches.

16 May 2007

West Nile virus case in court in Canada

Just as the first mosquitoes are appearing in parts of the United States carrying the West Nile virus, a court in Canada has ruled that an insurance company must pay a man compensation after he was bitten by a mosquito at work and developed the West Nile virus.

15 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).

9 May 2007

New treatments for brain hemorrhage

The first scientifically proven treatments for intracerebral hemorrhage, or "bleeding," strokes, are on the horizon, including a new drug that holds promise for slowing bleeding and limiting brain damage resulting from such a stroke, according to updated American Heart Association/American Stroke Association guidelines.

4 May 2007

Migraines may be sign of post-traumatic stress for Iraq veterans

Soldiers returning from combat in Iraq who have migraine headaches are more than twice as likely to also have symptoms of post-traumatic stress, depression or anxiety than soldiers who do not have migraines, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Renewal of Echinacea and St John's Wort research

A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years.

4 May 2007

Reclast found to cause abnormal heart rhythms

An osteoporosis drug with the potential to cut the risk of spine fractures by 70 percent and the chance of hip fractures by 41 percent, has been found to have an adverse side effect on some women.

3 May 2007

1758 cases of malaria reported in UK travellers in 2006

1386 of the cases were due to the potentially fatal Plasmodium falciparum which is a major international health risk and which kills more than a million people a year in Africa. 219 were due to Plasmodium vivax which causes a debilitating disease, but is rarely fatal.

2 May 2007